Because ipamorelin raises IGF-1 (insulin-like growth factor 1, a natural hormone), theres a theoretical risk that the peptide could negatively affect your blood sugar levels or accidentally speed up the growth of hidden, pre-existing tumors
[6] NAD+ augmentation may counteract age-related NAD+ loss caused by overactive NAD-consuming enzymes (such as the NADase CD38), thereby supporting mitochondrial maintenance and metabolic homeostasis
for patients with a known #chromosome rearrangement (#translocations) Its not for everyone- but it can be a #powerful #tool, especially when patients are of a higher #maternal age (over 37), where half or more #embryos are likely to be #chromosomally abnormal
It has been shown to inhibit LPS-induced expression of inflammatory cytokines and alleviate intestinal barrier injury by suppressing specific inflammasome activation (78)
In this scenario, developing a new class of anti-cancer drugs with greater selectivity and specificity against the different types of tumors is highly desirable
While the research is promising, more human studies are needed